| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.4 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.4 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.4 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |